![Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 | Journal of Virology Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 | Journal of Virology](https://journals.asm.org/cms/10.1128/JVI.01542-10/asset/86cfac07-d503-490b-8bb2-a605a92756b5/assets/graphic/zjv9990939980002.jpeg)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 | Journal of Virology
![Welcome to The Heritage Center - The Heritage Center and Indian River Citrus Museum, -Vero Beach, Florida - Vero Heritage Inc. is a non-profit organization dedicated to promoting the preservation of historic Welcome to The Heritage Center - The Heritage Center and Indian River Citrus Museum, -Vero Beach, Florida - Vero Heritage Inc. is a non-profit organization dedicated to promoting the preservation of historic](https://www.veroheritage.org/images/17190362_1378794388850587_1865075905562680689_n.jpg)
Welcome to The Heritage Center - The Heritage Center and Indian River Citrus Museum, -Vero Beach, Florida - Vero Heritage Inc. is a non-profit organization dedicated to promoting the preservation of historic
![Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/29733ad9-1ea4-45aa-abfb-29ff18a19919/gr1_lrg.gif)
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet
![Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan | Scientific Reports Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-86050-3/MediaObjects/41598_2021_86050_Fig3_HTML.png)
Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan | Scientific Reports
![Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro | Cell Research Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro | Cell Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41422-020-0282-0/MediaObjects/41422_2020_282_Fig1_HTML.png)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro | Cell Research
1 / 14 Appeal decision Appeal No. 2018-6610 Appellant Novartis AG Patent Attorney KAWAGUTI & PARTNERS INTELLECTUAL PROPERTY
![Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87735e5b-8b9b-408f-8b1f-29978d5602ea/gr2_lrg.jpg)
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet
![SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling | PNAS SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling | PNAS](https://www.pnas.org/cms/10.1073/pnas.2016650117/asset/8ac9c724-698f-4aad-a7a5-edae89e7fa5d/assets/images/large/pnas.2016650117fig01.jpg)